Oncotarget

VOLUME 5 (2014)

View Archive »

About The Cover

Effect of Entolimod on 5-FU toxicity in IL-6 knockout mice. See Kojouharov et al.

Table of Contents

Editorial Materials

Targeting leukemia stem cells: in vitro veritas

https://doi.org/10.18632/oncotarget.1777
575-576
PDF  |  How to cite

Reviews

Ras and autophagy in cancer development and therapy

https://doi.org/10.18632/oncotarget.1775
577-586
Abstract  |  PDF  |  Full Text  |  How to cite

Priority Research Papers

Immune regulation by low doses of the DNA methyltransferase inhibitor 5azacitidine in common human epithelial cancers

https://doi.org/10.18632/oncotarget.1782
587-598
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Research Papers

A differential role for CXCR4 in the regulation of normal versus malignant breast stem cell activity

https://doi.org/10.18632/oncotarget.1169
599-612
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Adiposederived mesenchymal stem cells ASCs may favour breast cancer recurrence via HGF/cMet signaling

https://doi.org/10.18632/oncotarget.1359
613-633
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NFκB regulated gene products in multiple myeloma xenograft mouse model

https://doi.org/10.18632/oncotarget.1596
634-648
Abstract  |  PDF  |  Full Text  |  How to cite

Lymphoid enhancer binding factor1 LEF1 expression as a prognostic factor in adult acute promyelocytic leukemia

https://doi.org/10.18632/oncotarget.1619
649-658
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Large scale integration of drugtarget information reveals polypharmacological drug action mechanisms in tumor cell line growth inhibition assays

https://doi.org/10.18632/oncotarget.1597
659-666
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Targeting CDC25C PLK1 and CHEK1 to overcome Docetaxel resistance induced by loss of LZTS1 in prostate cancer

https://doi.org/10.18632/oncotarget.1574
667-678
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Pcadherin signals through the laminin receptor α6β4 integrin to induce stem cell and invasive properties in basallike breast cancer cells

https://doi.org/10.18632/oncotarget.1459
679-692
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

AKT mediates actinomycin Dinduced p53 expression

https://doi.org/10.18632/oncotarget.1328
693-703
Abstract  |  PDF  |  Full Text  |  How to cite

Immunogenicity of targeted lentivectors

https://doi.org/10.18632/oncotarget.1680
704-715
Abstract  |  PDF  |  Full Text  |  How to cite

Cytotoxic effects of 15dPGJ2 against osteosarcoma through ROSmediated AKT and cell cycle inhibition

https://doi.org/10.18632/oncotarget.1704
716-725
Abstract  |  PDF  |  Full Text  |  How to cite

Synergistic antitumor activity of acadesine AICAR in combination with the antiCD20 monoclonal antibody rituximab in in vivo and in vitro models of mantle cell lymphoma

https://doi.org/10.18632/oncotarget.1455
726-739
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Sp1mediated microRNA182 expression regulates lung cancer progression

https://doi.org/10.18632/oncotarget.1608
740-753
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

MUC1C nuclear localization drives invasiveness of renal cancer cells through a sheddase/gamma secretase dependent pathway

https://doi.org/10.18632/oncotarget.1768
754-763
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Identification of a long noncoding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer

https://doi.org/10.18632/oncotarget.1769
764-774
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite
Special Collection ToC

Targeting Srcmediated Tyr216 phosphorylation and activation of GSK3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo

https://doi.org/10.18632/oncotarget.1770
775-787
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

LIF promotes tumorigenesis and metastasis of breast cancer through the AKTmTOR pathway

https://doi.org/10.18632/oncotarget.1772
788-801
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Tolllike receptor5 agonist Entolimod broadens the therapeutic window of 5fluorouracil by reducing its toxicity to normal tissues in mice

https://doi.org/10.18632/oncotarget.1773
802-814
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

PHLPP2 suppresses the NFκB pathway by inactivating IKKβ kinase

https://doi.org/10.18632/oncotarget.1774
815-823
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Serum microRNA expression patterns that predict early treatment failure in prostate cancer patients

https://doi.org/10.18632/oncotarget.1776
824-840
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Hydrogen peroxide/ATRChk2 activation mediates p53 protein stabilization and anticancer activity of cheliensisin A in human cancer cells

https://doi.org/10.18632/oncotarget.1780
841-852
Abstract  |  PDF  |  Full Text  |  How to cite

Frequent L1 retrotranspositions originating from TTC28 in colorectal cancer

https://doi.org/10.18632/oncotarget.1781
853-859
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite


Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
By using our site you are giving us permission to use cookies. This website collects cookies to deliver a better user experience, and to analyze our website traffic and performance. Personal data is not collected.